<ref xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="B114"><label>114</label><mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lemos</surname><given-names>ACB</given-names></name><name><surname>Do Esp&#237;rito Santo</surname><given-names>DA</given-names></name><name><surname>Salvetti</surname><given-names>MC</given-names></name><name><surname>Gilio</surname><given-names>RN</given-names></name><name><surname>Agra</surname><given-names>LB</given-names></name><name><surname>Pazin-Filho</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)</article-title>. <source>Thromb Res</source>. (<year>2020</year>) <volume>196</volume>:<page-range>359&#8211;66</page-range>. doi:&#160;<pub-id pub-id-type="doi">10.1016/j.thromres.2020.09.026</pub-id>, PMID: <?supplied-pmid 32977137?><pub-id pub-id-type="pmid">32977137</pub-id>
</mixed-citation></ref>